Clinical trials of Spanish tuberculosis TB vaccine MTBVAC have begun in India

Clinical trials of Spanish tuberculosis TB vaccine MTBVAC have begun in India

Bharat Biotech, in collaboration with biopharmaceutical company Biofarbi, has developed TB vaccine. This vaccine has been specially made for the youth of India so that they can be successful in fighting this disease. This is going to prove to be a milestone in the fight against TB. This vaccine is more effective than the earlier TB vaccine BCG. Bharat Biotech has created the first vaccine MTBVAC from human source. Bharat Biotech has announced MTBVAC, the first TB vaccine made from human source. Clinical trials series of MTBVAC is going to…

Read More

after covishield new study find side effects of Covaxin read full article in hindi

after covishield new study find side effects of Covaxin read full article in hindi

There was an uproar in the entire country and the world regarding the side effects of Covishield. Now meanwhile, a report has also come regarding Covaxin. It has been clearly stated in this report that side effects have also been observed in those who have received Covaxin. Report on side effects of Covaxin after Covishield To avoid the Corona epidemic, people got the Covid vaccine. During the Corona epidemic, some people got Covishield installed. Some people got Covaxin. Just a few days ago, people were scared of the news of…

Read More

Bharat Biotech Nasal Vaccine Incovac Will Be Launched On Republic Day 26 Januray In India

Bharat Biotech Nasal Vaccine Incovac Will Be Launched On Republic Day 26 Januray In India

Nasal Covid-19 Vaccine: The first intranasal Kovid-19 vaccine ‘Incovac’ developed in the country will be started to be given to the people from 26 January. Company’s Chairman and Managing Director Krishna Ella gave this information. It has been made by Swadeshi Bharat Biotech. This vaccine was approved by the Government of India on December 23 last year amidst the growing havoc of Corona in China. During a conversation with students at the India International Science Festival (IISF) held in Bhopal, Krishna Ella told that the Nasal vaccine will be officially…

Read More

Bharat Biotech To Launch India’s First Nasal Coronavirus Vaccine On 26 January

Bharat Biotech To Launch India’s First Nasal Coronavirus Vaccine On 26 January

Bharat Biotech Coronavirus Nasal Vaccine: The fight against the corona virus is still going on and the biggest weapon in it is the vaccine. This is the reason why pharma companies are continuously experimenting with this. Now soon the country is going to get the first intranasal vaccine (to be given through the nose). Bharat Biotech will launch its Nasal Kovid-19 vaccine iNCOVACC on 26 January. Company’s executive chairman Krishna Ella gave information about this in a program on Saturday. Speaking at the ongoing India International Science Festival at the…

Read More

Bharat Biotech INCOVACC Intranasal Covid Vaccine Approved Will Be Used In Such Situation

Bharat Biotech INCOVACC Intranasal Covid Vaccine Approved Will Be Used In Such Situation

iNCOVACC Intra-Nasal Covid Vaccine: Bharat Biotech International Limited announced on Monday (28 November) that Incovacc (iNCOVACC BBV154) has become the world’s first covid vaccine to be administered through the nose (without a needle). In English it is called Intra-Nasal Covid Vaccine. The company said in a press release that the Central Drugs Standard Control Organization (CDSCO) has approved both its dosage forms – primary series and heterologous – for all adults under controlled use in emergency situations. This means that people of 18 years of age or older in India…

Read More